Citadel Advisors’s PolyPid PYPD Stock Holding History
Bought
Maintained
Sold
Other funds holding PYPD
ACM
RA
DCM
ACM
SPM
JGC
Citadel Advisors's PYPD Position: Q2 2026 in Review
Citadel Advisors reduced its PolyPid (PYPD) stake by 27% in Q2 2026, selling an estimated $71.4K and leaving 42,282 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #11906.
Citadel Advisors first reported a position in PYPD in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.65M in Q2 2020. 33 funds tracked by Wall St. Rank hold PYPD as of Q2 2026.
- Citadel Advisors held 42,282 shares of PolyPid worth $215K as of Q2 2026.
- Citadel Advisors sold 15,487 PolyPid shares in Q2 2026, an estimated $71.4K.
- PolyPid made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11906 holding.
- Citadel Advisors first reported a position in PolyPid in Q2 2020 and has held it in 12 quarters since.
- Citadel Advisors's PolyPid position peaked at $1.65M in Q2 2020.
- 33 funds tracked by Wall St. Rank held PolyPid as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.